Q4 2012
Read transcript →KL
Kalaris Therapeutics Inc (KLRS) Earnings Call Transcripts
NASDAQ·Healthcare·Biotechnology
$2.49
+2.89%
Mkt Cap $65.65M
Q3 2012
Read transcript →Q2 2012
Read transcript →Q1 2010
Read transcript →Q4 2009
Read transcript →Q3 2007
Read transcript →Q1 2007
Read transcript →Q4 2006
Read transcript →Q3 2006
Read transcript →Q2 2006
Read transcript →Q1 2006
Read transcript →Q4 2005
Read transcript →